Montelukast Tablet, Chewable
Product Images NDC 63187-626

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Montelukast (NDC 63187-626). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Monte Tab Alkem Figure 01)

This appears to be a chart showing the change in height (measured in centimeters) over a period of weeks for three groups of participants (120 taking Monteukast Sodum & mg, 119 taking Bodiomeinasono 338 mg, and 121 taking a placebo). The chart displays data at weeks 8, 16, 21, 32, 40, 48, but it is not possible to draw conclusions without more context about the study being conducted.*

FDA Label Image

Chemical Structure (Monte Tab Alkem Figure 02)

FDA Label Image

Figure 2 (Monte Tab Alkem Figure 03)

FDA Label Image

63187-626-30 (Monte Tab Alkem Figure 06)

This is a description of a medication called Montelukast Sodium 5mg, consisting of 30 chewable tablets in a pack. The tablets are pink, rounded, bi-convex-shaped, and debossed with "AUM102" on one side and plain on the other side. The medication is RX only and is manufactured in India by Kemwell Biopharma Pvt. Ltd. The NDC for this medication is 63187-626-30 and the lot number is 00000 with an expiration date of 00/00/00. The medication should be stored at 25°C (77°F) and kept out of the reach of children.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.